Prognostic factors in endometrial clear cell carcinoma.

Cetinkaya, Nilufer; Selcuk, Ilker; Ozdal, Bulent; Meydanli, Mehmet Mutlu; Gungor, Tayfun

Cetinkaya, Nilufer; Selcuk, Ilker; Ozdal, Bulent; Meydanli, Mehmet Mutlu; Gungor, Tayfun.

Afiliação

Cetinkaya N; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Hamamonu, 06230, Ankara, Turkey. cetinkayanilufer@gmail.com.
Selcuk I; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Hamamonu, 06230, Ankara, Turkey.
Ozdal B; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Hamamonu, 06230, Ankara, Turkey.
Meydanli MM; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Hamamonu, 06230, Ankara, Turkey.
Gungor T; Department of Obstetrics and Gynecology, Hitit University Medical Faculty, Çorum, Turkey.

Arch Gynecol Obstet ; 295(1): 189-195, 2017 Jan.

Article em En | MEDLINE | ID: mdl-27549092

Assuntos

Adenocarcinoma de Células Claras/patologia; Antígeno Ca-125/sangue; Neoplasias do Endométrio/patologia; Idoso; Idoso de 80 Anos ou mais; Braquiterapia; Terapia Combinada; Intervalo Livre de Doença; Feminino; Humanos; Metástase Linfática; Pessoa de Meia-Idade; Estadiamento de Neoplasias; Prognóstico; Estudos Retrospectivos; Taxa de Sobrevida

Palavras-chave

Clear cell carcinoma; ECCC; Endometrial carcinoma; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Adenocarcinoma de Células Claras / Antígeno Ca-125 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Arch Gynecol Obstet Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google